A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Camostat Mesilate in Patients with COVID-19 (CANDLE Study)

Researchers investigated whether camostat mesilate is an effective treatment for SARS-CoV-2 infection. This was a multicenter, double-blind, randomized, parallel-group, placebo-controlled study.